Fill Finish
ABL Europe
ABL Europe provides viral vector aseptic drug product manufacturing services in-house using a Bausch and Straubel filling machine located in a rigid isolator. Automated liquid filling operations are aseptically validated using Pharmaceutical industry standard vials and stoppers, providing clients the security of an integrity tested, container / closure with a long-term supply chain.
ABL offers the following filling and finishing operations:
- DIN 2R and 2mL type 1 borosilicate glass vials
- 13 mm bromobutyl stoppers and flip-off caps
- 10,000 vials per batch (filling speed 3,000 units per hour)
- Phase 1 – 3 clinical supply, including engineering / toxicology supply runs
- Process validation batches
- Manufacturing process hold / product stability runs
- Fully comprehensive in-house QC release & stability testing
Process Validation
ABL draws on its expertise & experience to design production processes that optimize product yields, minimize regulatory risk & speed the time to clinic.
Quality Control
ABL Europe has a particularly strong in-house analytical function providing a wide range of viral vector product specific QC methods in addition to generic pharmacopeia procedures.
GMP Manufacturing
With a brand new 200 L stirred single use bioreactor (SUB) facility, ABL has strengthened its position in the GMP viral vector CMO market to support clients
Fill / Finish
ABL Europe provides viral vector aseptic drug product manufacturing services in-house using a Bausch and Straubel filling machine located in a rigid isolator.
